Quick Answer
Avricore Health Inc. reported R&D Expense of $251.5 thousand for fiscal year 2018.
Avricore Health Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2018 | $251.5K | +3.8% |
| 2017 | $242.3K | +16.1% |
| 2016 | $208.8K | — |
- Avricore Health Inc. showed an increase of +3.8% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2018 period, Avricore Health Inc.’s r&d expense has grown by 20.5% (from $208.8 thousand to $251.5 thousand).
- The most recent figure is from Avricore Health Inc.’s fiscal year 2018 report (Form 20-F), filed with the SEC on June 17, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: